Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABRIDGE: Enoxaparin Bridging in Mechanical Valve Replacement
NCT00298285Phase 4Completed
- Sponsor
- Cleveland Clinic
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of enoxaparin in arterial thromboembolism (2 arms), sponsored by Cleveland Clinic. Primary endpoints: Rate of Arterial Thromboembolism at 30 days and Rate of Major Bleeding at 30 days. Status: completed.
02
Drugs
enoxaparin
03
Conditions
arterial thromboembolism
Beyond the preview
Go deeper on NCT00298285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298285.